|
TMSB15B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.996000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.961850E-02 |
| Normal-vs-Stage2 |
1.980250E-01 |
| Normal-vs-Stage3 |
4.588400E-02 |
| Normal-vs-Stage4 |
7.744400E-01 |
| Stage1-vs-Stage2 |
9.621600E-03 |
| Stage1-vs-Stage3 |
9.347400E-01 |
| Stage1-vs-Stage4 |
2.362400E-01 |
| Stage2-vs-Stage3 |
9.360500E-03 |
| Stage2-vs-Stage4 |
2.000000E-01 |
| Stage3-vs-Stage4 |
2.238600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.460500E-02 |
| Normal-vs-AfricanAmerican |
4.131800E-01 |
| Normal-vs-Asian |
2.701900E-02 |
| Caucasian-vs-AfricanAmerican |
8.436600E-01 |
| Caucasian-vs-Asian |
1.960240E-01 |
| AfricanAmerican-vs-Asian |
5.480400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.644300E-02 |
| Normal-vs-Female |
1.019370E-01 |
| Male-vs-Female |
6.308400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.795600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.201000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.746600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.131400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.414500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.197500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.427400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.081000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.130800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.463600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.369000E-01 |
| Classical-VS-Follicular |
7.84500000000632E-05 |
| Classical-VS-Other |
6.289000E-01 |
| Classical-VS-Normal |
4.303400E-03 |
| Tall-VS-Follicular |
6.676000E-03 |
| Tall-VS-Other |
7.654200E-01 |
| Tall-VS-Normal |
6.168400E-02 |
| Follicular-VS-Other |
7.557800E-02 |
| Follicular-VS-Normal |
1.094810E-01 |
| Other-VS-Normal |
3.191800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.750770E-01 |
| Normal-vs-N1 |
2.197200E-01 |
| N0-vs-N1 |
8.847600E-01 |
|
|
